Patient with Malignant Granular Cell Tumor Treated with Sunitinib Malate
Soonchunhyang Medical Science
; : 66-69, 2012.
Article
em Ko
| WPRIM
| ID: wpr-43356
Biblioteca responsável:
WPRO
ABSTRACT
Malignant granular cell tumors (MGST) are extremely rare, high-grade sarcoma of schwann cell origin. They often metastasize and are associated with short survival. We described a patient with recurred MGST after wide marginal excision followed by chemotherapy. The histologic findings revealed relapsed MGST containing rich vascular structure. The patient was treated with sunitinib malate (50 mg/day) for three weeks. Because sunitinib malate has a potent antiangiogenic property, we surmised that it might be effective against this type of malignancy. However, he died due to progression of tumor after six weeks. Here, we report it along with the corresponding literature.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Pirróis
/
Sarcoma
/
Tumor de Células Granulares
/
Indóis
Limite:
Humans
Idioma:
Ko
Revista:
Soonchunhyang Medical Science
Ano de publicação:
2012
Tipo de documento:
Article